Ligand director John W. Kozarich sells USD 572,598 common shares

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

LGND

0.00
  • Ligand Pharmaceuticals director John W. Kozarich cut direct common stock holdings to 41,786 shares following sales on May 1, May 12, May 13.
  • Disposed of 2,501 shares at prices mostly between USD 223.5 and USD 234.09.
  • Also exercised non-qualified stock options for 2,034 shares at USD 69.51, then sold the same 2,034 shares at about USD 223.5 to USD 224.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001011-26-000049), on May 14, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.